Incidence of suspicious axillary lymph node involvement in fluorine-18 fluoro-D-glucose positron emission tomography/computed tomography in gynecologic cancers/Jinekolojik kanserlerde flor-18 floro-D-glukoz pozitron emisyon tomografisi-bilgisayarli tomografide supheli aksiller lenf nodu tutulumunun insidansi
Objective: There is scarce information about axillary lymph node involvement in gynecologic cancers. We analyzed the incidence of suspicious axillary lymph nodes in gynecologic cancers. Materials and Methods: We retrospectively analyzed the positron emission tomography/computed tomography findings o...
Gespeichert in:
Veröffentlicht in: | Turkish journal of obstetrics and gynecology 2018-06, Vol.15 (2), p.99 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 2 |
container_start_page | 99 |
container_title | Turkish journal of obstetrics and gynecology |
container_volume | 15 |
creator | Raoufi, Jalal Iscan, Serhan Can Hanedan, Candost Ozkan, Emine Elif Cerci, Sevim Sureyya Erdemoglu, Ebru Erdemoglu, Evrim |
description | Objective: There is scarce information about axillary lymph node involvement in gynecologic cancers. We analyzed the incidence of suspicious axillary lymph nodes in gynecologic cancers. Materials and Methods: We retrospectively analyzed the positron emission tomography/computed tomography findings of 251 patients with endometrial, cervical, and ovarian cancer. There is no cut-off value documented for axillary metastases from gynecologic cancers; therefore we adopted the cut-off standardized uptake values (SUVs) proclaimed in breast cancer. Results: A total of 251 patients records were available for analysis; 40 patients (15.9%) with suspicious axillary lymph nodes were included in the study. Twenty-one and a half percent (n=20/93) of patients with endometrium cancer, 14.1% (n=14/99) of patients with ovarian cancer, and 10% (n=6/59) of those with cervical cancer had suspicious axillary lymph nodes. Patients with an maximum SUV ([SUV.sub.max]) uptake higher than 3 underwent axillary lymph node biopsy. None of them was found to have axillary metastases of gynecologic cancers in the pathologic evaluation. In one patient with endometrial cancer, an obscure breast ductal carcinoma was diagnosed, another patient with endometrial cancer was found to have follicular lymphoma. The third patient with endometrial cancer had no malignancy in axillary lymph node biopsy, but had Hurthle cell neoplasia in a thyroid biopsy; the patient did not accept any surgical or medical treatment for endometrial cancer and died 23 months later. There were three (7.5%) metachronous cancers out of 40 gynecologic cancers; two patients were explained above, the third patient with endometrium cancer, who was not histopathologically evaluated although the axillary [SUV.sub.max] was |
doi_str_mv | 10.4274/tjod.12144 |
format | Article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A556734428</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A556734428</galeid><sourcerecordid>A556734428</sourcerecordid><originalsourceid>FETCH-LOGICAL-g678-4e827afd04d283d5845ca8b8345680233d15636c91ede341247a44f1f9f5b0623</originalsourceid><addsrcrecordid>eNptUMtu3CAUdaVWajTNpl-A1LVnDMaPWUbpI6kidZN9xMDFc8eYa4GJ6nx9iabqZFGxuEfnwnlQFJ95tZWik7vlRGbLBZfyfXGVx77c10J8LK5jPFVVxfuu23Nx9a659xoNeA2MLIspzqiRUmTqNzqnwsrcOs1H5skAQ_9M7hkm8EvGzLpEAT2UvD9jKr-Wg0uaIrCZIi6BPIMJY8QMFppoCGo-rjtN05wWMG-4V8Fh9aDJ0YCaaZUzhbj7mQ3GzJ1wZKPyEYKDkLNYR-Fs_M93pJds-3KxXS-uFiOWB3QDRrWq4PCyyGIxzUfInBpjbg2BOfD2tXNiS1qSS1PyyeeIEU3OgJ-KD1a5CNd_56Z4_P7t8faufPj14_725qEc2q4vJfSiU9ZU0oi-Nk0vG636Q1_Lpu0rUdeGN23d6j0HA7XkQnZKSsvt3jaHqhX1pvhylh2Ugyf0lpagdC6mn26apu1qKbPwptj-51Y-Jv-BJg8WM__mwR_XArY7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Incidence of suspicious axillary lymph node involvement in fluorine-18 fluoro-D-glucose positron emission tomography/computed tomography in gynecologic cancers/Jinekolojik kanserlerde flor-18 floro-D-glukoz pozitron emisyon tomografisi-bilgisayarli tomografide supheli aksiller lenf nodu tutulumunun insidansi</title><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Raoufi, Jalal ; Iscan, Serhan Can ; Hanedan, Candost ; Ozkan, Emine Elif ; Cerci, Sevim Sureyya ; Erdemoglu, Ebru ; Erdemoglu, Evrim</creator><creatorcontrib>Raoufi, Jalal ; Iscan, Serhan Can ; Hanedan, Candost ; Ozkan, Emine Elif ; Cerci, Sevim Sureyya ; Erdemoglu, Ebru ; Erdemoglu, Evrim</creatorcontrib><description>Objective: There is scarce information about axillary lymph node involvement in gynecologic cancers. We analyzed the incidence of suspicious axillary lymph nodes in gynecologic cancers. Materials and Methods: We retrospectively analyzed the positron emission tomography/computed tomography findings of 251 patients with endometrial, cervical, and ovarian cancer. There is no cut-off value documented for axillary metastases from gynecologic cancers; therefore we adopted the cut-off standardized uptake values (SUVs) proclaimed in breast cancer. Results: A total of 251 patients records were available for analysis; 40 patients (15.9%) with suspicious axillary lymph nodes were included in the study. Twenty-one and a half percent (n=20/93) of patients with endometrium cancer, 14.1% (n=14/99) of patients with ovarian cancer, and 10% (n=6/59) of those with cervical cancer had suspicious axillary lymph nodes. Patients with an maximum SUV ([SUV.sub.max]) uptake higher than 3 underwent axillary lymph node biopsy. None of them was found to have axillary metastases of gynecologic cancers in the pathologic evaluation. In one patient with endometrial cancer, an obscure breast ductal carcinoma was diagnosed, another patient with endometrial cancer was found to have follicular lymphoma. The third patient with endometrial cancer had no malignancy in axillary lymph node biopsy, but had Hurthle cell neoplasia in a thyroid biopsy; the patient did not accept any surgical or medical treatment for endometrial cancer and died 23 months later. There were three (7.5%) metachronous cancers out of 40 gynecologic cancers; two patients were explained above, the third patient with endometrium cancer, who was not histopathologically evaluated although the axillary [SUV.sub.max] was <3, had rectosigmoid cancer and glioblastoma metachronously. Conclusion: Our study shows that an important ratio (14-21%) of patients with gynecologic cancer has suspicious axillary lymph nodes. Increased [SUV.sub.max], particularly above 3, might be used as an indication for axillary biopsy and may help to identify secondary metastatic cancer. Keywords: Gynecologic cancers, maximum standardized uptake value, positron emission tomography/computed tomography, metachronous, axillary lymph node Amac: Jinekolojik kanserlerde aksiller lenf nodu tutulumunun prognostik onemi ve tedavisi acisindan kisitli bilgiler mevcuttur. Bu calismanin amaci, jinekolojik kanserlerde supheli aksiller lenf nodu insidansini degerlendirmektir. Gerec ve Yontem: Klinigimize basvuran toplam 251 endometrium, serviks veya over kanseri tanisi konulmus hastalarin pozitron emisyon tomografsi-bilgisayarli tomograf bulgularini retrospektif olarak analiz ettik. Jinekolojik kanserler icin aksiller metastazi acidan belgelenen herhangi bir sinir deger belirlenmemis olmasi nedeniyle calismamizda meme kanseri icin belirlenen standart uptake degerini (SUV) sinir deger olarak kabul ettik. Bulgular: Analizler icin toplam 251 hasta kaydi mevcuttu. Supheli aksiller lenf nodu olan 40 hasta (%15,9) calismaya dahil edildi. Endometrium kanseri olan hastalarin %21,5'inde (n=20/93), over kanseri olan hastalarin %14,1'inde (n=14/99) ve serviks kanseri olan hastalarin %10'unda (n=6/59) supheli aksiller lenf nodu tespit edildi. Maksimum SUV ([SUV.sub.maks]) degeri 3'ten yuksek bulunan 5 hastada aksiller lenf nodundan biyopsi alindi. Patolojik degerlendirmede hicbir hastada primer jinekolojik kansere ait aksiller metastaz saptanmadi. Endometrium kanseri olan bir hastada invaziv meme karsinomu, endometrium kanseri olan baska bir hastada folikuler lenfoma tanisi konuldu. Endometrium kanseri olan ucuncu hastada aksiller lenf nodu biyopsisinde tumor tespit edilmedi ancak tiroid biyopsisinde Hurthle hucre neoplazisi saptandi, bu hasta endometrium kanseri icin herhangi bir cerrahi veya medikal tedaviyi kabul etmedi ve 23 ay sonra hayatini kaybetmistir. Calismamiza supheli aksiller lenf nodu ile dahil olan 40 hastanin 3'unde (%7,5) metakron kanser izlendi; iki hasta yukaridaki paragrafta aciklandi, ucuncu ve endometrium kanser tanisi olan hastada rektosigmoid kanseri ve glioblastoma metakron olarak izlendi, bu hastaya [SUV.sub.maks] <3 olmasi nedeniyle aksiller lenf nodu biyopsisi yapilmamistir. Sonuc: Calismamizda, jinekolojik kanserli hastalarin onemli bir oraninin (%14-21) supheli lenf nodu gozlenmektedir. [SUV.sub.maks] ozellikle 3'un uzerinde olan olgularda aksiller lenf nodu biyopsisi yapilmasi muhtemel ikincil metastatik kanserin belirlemesinde yardimci olabilir. Anahtar Kelimeler: Jinekolojik kanserler, maksimum standart uptake degeri, pozitron emisyon tomografsi/bilgisayarli tomograf metakron, aksiller lenf nodu PRECIS: In gynecologic cancers, patients with suspicious axillary lymph nodes need to be evaluated and further investigated to exclude other causes.</description><identifier>ISSN: 2149-9322</identifier><identifier>DOI: 10.4274/tjod.12144</identifier><language>eng</language><publisher>Galenos Yayinevi Tic. Ltd</publisher><subject>Care and treatment ; CAT scans ; Diagnosis ; Lymph nodes ; Ovarian cancer</subject><ispartof>Turkish journal of obstetrics and gynecology, 2018-06, Vol.15 (2), p.99</ispartof><rights>COPYRIGHT 2018 Galenos Yayinevi Tic. Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>Raoufi, Jalal</creatorcontrib><creatorcontrib>Iscan, Serhan Can</creatorcontrib><creatorcontrib>Hanedan, Candost</creatorcontrib><creatorcontrib>Ozkan, Emine Elif</creatorcontrib><creatorcontrib>Cerci, Sevim Sureyya</creatorcontrib><creatorcontrib>Erdemoglu, Ebru</creatorcontrib><creatorcontrib>Erdemoglu, Evrim</creatorcontrib><title>Incidence of suspicious axillary lymph node involvement in fluorine-18 fluoro-D-glucose positron emission tomography/computed tomography in gynecologic cancers/Jinekolojik kanserlerde flor-18 floro-D-glukoz pozitron emisyon tomografisi-bilgisayarli tomografide supheli aksiller lenf nodu tutulumunun insidansi</title><title>Turkish journal of obstetrics and gynecology</title><description>Objective: There is scarce information about axillary lymph node involvement in gynecologic cancers. We analyzed the incidence of suspicious axillary lymph nodes in gynecologic cancers. Materials and Methods: We retrospectively analyzed the positron emission tomography/computed tomography findings of 251 patients with endometrial, cervical, and ovarian cancer. There is no cut-off value documented for axillary metastases from gynecologic cancers; therefore we adopted the cut-off standardized uptake values (SUVs) proclaimed in breast cancer. Results: A total of 251 patients records were available for analysis; 40 patients (15.9%) with suspicious axillary lymph nodes were included in the study. Twenty-one and a half percent (n=20/93) of patients with endometrium cancer, 14.1% (n=14/99) of patients with ovarian cancer, and 10% (n=6/59) of those with cervical cancer had suspicious axillary lymph nodes. Patients with an maximum SUV ([SUV.sub.max]) uptake higher than 3 underwent axillary lymph node biopsy. None of them was found to have axillary metastases of gynecologic cancers in the pathologic evaluation. In one patient with endometrial cancer, an obscure breast ductal carcinoma was diagnosed, another patient with endometrial cancer was found to have follicular lymphoma. The third patient with endometrial cancer had no malignancy in axillary lymph node biopsy, but had Hurthle cell neoplasia in a thyroid biopsy; the patient did not accept any surgical or medical treatment for endometrial cancer and died 23 months later. There were three (7.5%) metachronous cancers out of 40 gynecologic cancers; two patients were explained above, the third patient with endometrium cancer, who was not histopathologically evaluated although the axillary [SUV.sub.max] was <3, had rectosigmoid cancer and glioblastoma metachronously. Conclusion: Our study shows that an important ratio (14-21%) of patients with gynecologic cancer has suspicious axillary lymph nodes. Increased [SUV.sub.max], particularly above 3, might be used as an indication for axillary biopsy and may help to identify secondary metastatic cancer. Keywords: Gynecologic cancers, maximum standardized uptake value, positron emission tomography/computed tomography, metachronous, axillary lymph node Amac: Jinekolojik kanserlerde aksiller lenf nodu tutulumunun prognostik onemi ve tedavisi acisindan kisitli bilgiler mevcuttur. Bu calismanin amaci, jinekolojik kanserlerde supheli aksiller lenf nodu insidansini degerlendirmektir. Gerec ve Yontem: Klinigimize basvuran toplam 251 endometrium, serviks veya over kanseri tanisi konulmus hastalarin pozitron emisyon tomografsi-bilgisayarli tomograf bulgularini retrospektif olarak analiz ettik. Jinekolojik kanserler icin aksiller metastazi acidan belgelenen herhangi bir sinir deger belirlenmemis olmasi nedeniyle calismamizda meme kanseri icin belirlenen standart uptake degerini (SUV) sinir deger olarak kabul ettik. Bulgular: Analizler icin toplam 251 hasta kaydi mevcuttu. Supheli aksiller lenf nodu olan 40 hasta (%15,9) calismaya dahil edildi. Endometrium kanseri olan hastalarin %21,5'inde (n=20/93), over kanseri olan hastalarin %14,1'inde (n=14/99) ve serviks kanseri olan hastalarin %10'unda (n=6/59) supheli aksiller lenf nodu tespit edildi. Maksimum SUV ([SUV.sub.maks]) degeri 3'ten yuksek bulunan 5 hastada aksiller lenf nodundan biyopsi alindi. Patolojik degerlendirmede hicbir hastada primer jinekolojik kansere ait aksiller metastaz saptanmadi. Endometrium kanseri olan bir hastada invaziv meme karsinomu, endometrium kanseri olan baska bir hastada folikuler lenfoma tanisi konuldu. Endometrium kanseri olan ucuncu hastada aksiller lenf nodu biyopsisinde tumor tespit edilmedi ancak tiroid biyopsisinde Hurthle hucre neoplazisi saptandi, bu hasta endometrium kanseri icin herhangi bir cerrahi veya medikal tedaviyi kabul etmedi ve 23 ay sonra hayatini kaybetmistir. Calismamiza supheli aksiller lenf nodu ile dahil olan 40 hastanin 3'unde (%7,5) metakron kanser izlendi; iki hasta yukaridaki paragrafta aciklandi, ucuncu ve endometrium kanser tanisi olan hastada rektosigmoid kanseri ve glioblastoma metakron olarak izlendi, bu hastaya [SUV.sub.maks] <3 olmasi nedeniyle aksiller lenf nodu biyopsisi yapilmamistir. Sonuc: Calismamizda, jinekolojik kanserli hastalarin onemli bir oraninin (%14-21) supheli lenf nodu gozlenmektedir. [SUV.sub.maks] ozellikle 3'un uzerinde olan olgularda aksiller lenf nodu biyopsisi yapilmasi muhtemel ikincil metastatik kanserin belirlemesinde yardimci olabilir. Anahtar Kelimeler: Jinekolojik kanserler, maksimum standart uptake degeri, pozitron emisyon tomografsi/bilgisayarli tomograf metakron, aksiller lenf nodu PRECIS: In gynecologic cancers, patients with suspicious axillary lymph nodes need to be evaluated and further investigated to exclude other causes.</description><subject>Care and treatment</subject><subject>CAT scans</subject><subject>Diagnosis</subject><subject>Lymph nodes</subject><subject>Ovarian cancer</subject><issn>2149-9322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptUMtu3CAUdaVWajTNpl-A1LVnDMaPWUbpI6kidZN9xMDFc8eYa4GJ6nx9iabqZFGxuEfnwnlQFJ95tZWik7vlRGbLBZfyfXGVx77c10J8LK5jPFVVxfuu23Nx9a659xoNeA2MLIspzqiRUmTqNzqnwsrcOs1H5skAQ_9M7hkm8EvGzLpEAT2UvD9jKr-Wg0uaIrCZIi6BPIMJY8QMFppoCGo-rjtN05wWMG-4V8Fh9aDJ0YCaaZUzhbj7mQ3GzJ1wZKPyEYKDkLNYR-Fs_M93pJds-3KxXS-uFiOWB3QDRrWq4PCyyGIxzUfInBpjbg2BOfD2tXNiS1qSS1PyyeeIEU3OgJ-KD1a5CNd_56Z4_P7t8faufPj14_725qEc2q4vJfSiU9ZU0oi-Nk0vG636Q1_Lpu0rUdeGN23d6j0HA7XkQnZKSsvt3jaHqhX1pvhylh2Ugyf0lpagdC6mn26apu1qKbPwptj-51Y-Jv-BJg8WM__mwR_XArY7</recordid><startdate>20180601</startdate><enddate>20180601</enddate><creator>Raoufi, Jalal</creator><creator>Iscan, Serhan Can</creator><creator>Hanedan, Candost</creator><creator>Ozkan, Emine Elif</creator><creator>Cerci, Sevim Sureyya</creator><creator>Erdemoglu, Ebru</creator><creator>Erdemoglu, Evrim</creator><general>Galenos Yayinevi Tic. Ltd</general><scope/></search><sort><creationdate>20180601</creationdate><title>Incidence of suspicious axillary lymph node involvement in fluorine-18 fluoro-D-glucose positron emission tomography/computed tomography in gynecologic cancers/Jinekolojik kanserlerde flor-18 floro-D-glukoz pozitron emisyon tomografisi-bilgisayarli tomografide supheli aksiller lenf nodu tutulumunun insidansi</title><author>Raoufi, Jalal ; Iscan, Serhan Can ; Hanedan, Candost ; Ozkan, Emine Elif ; Cerci, Sevim Sureyya ; Erdemoglu, Ebru ; Erdemoglu, Evrim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g678-4e827afd04d283d5845ca8b8345680233d15636c91ede341247a44f1f9f5b0623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Care and treatment</topic><topic>CAT scans</topic><topic>Diagnosis</topic><topic>Lymph nodes</topic><topic>Ovarian cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raoufi, Jalal</creatorcontrib><creatorcontrib>Iscan, Serhan Can</creatorcontrib><creatorcontrib>Hanedan, Candost</creatorcontrib><creatorcontrib>Ozkan, Emine Elif</creatorcontrib><creatorcontrib>Cerci, Sevim Sureyya</creatorcontrib><creatorcontrib>Erdemoglu, Ebru</creatorcontrib><creatorcontrib>Erdemoglu, Evrim</creatorcontrib><jtitle>Turkish journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raoufi, Jalal</au><au>Iscan, Serhan Can</au><au>Hanedan, Candost</au><au>Ozkan, Emine Elif</au><au>Cerci, Sevim Sureyya</au><au>Erdemoglu, Ebru</au><au>Erdemoglu, Evrim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence of suspicious axillary lymph node involvement in fluorine-18 fluoro-D-glucose positron emission tomography/computed tomography in gynecologic cancers/Jinekolojik kanserlerde flor-18 floro-D-glukoz pozitron emisyon tomografisi-bilgisayarli tomografide supheli aksiller lenf nodu tutulumunun insidansi</atitle><jtitle>Turkish journal of obstetrics and gynecology</jtitle><date>2018-06-01</date><risdate>2018</risdate><volume>15</volume><issue>2</issue><spage>99</spage><pages>99-</pages><issn>2149-9322</issn><abstract>Objective: There is scarce information about axillary lymph node involvement in gynecologic cancers. We analyzed the incidence of suspicious axillary lymph nodes in gynecologic cancers. Materials and Methods: We retrospectively analyzed the positron emission tomography/computed tomography findings of 251 patients with endometrial, cervical, and ovarian cancer. There is no cut-off value documented for axillary metastases from gynecologic cancers; therefore we adopted the cut-off standardized uptake values (SUVs) proclaimed in breast cancer. Results: A total of 251 patients records were available for analysis; 40 patients (15.9%) with suspicious axillary lymph nodes were included in the study. Twenty-one and a half percent (n=20/93) of patients with endometrium cancer, 14.1% (n=14/99) of patients with ovarian cancer, and 10% (n=6/59) of those with cervical cancer had suspicious axillary lymph nodes. Patients with an maximum SUV ([SUV.sub.max]) uptake higher than 3 underwent axillary lymph node biopsy. None of them was found to have axillary metastases of gynecologic cancers in the pathologic evaluation. In one patient with endometrial cancer, an obscure breast ductal carcinoma was diagnosed, another patient with endometrial cancer was found to have follicular lymphoma. The third patient with endometrial cancer had no malignancy in axillary lymph node biopsy, but had Hurthle cell neoplasia in a thyroid biopsy; the patient did not accept any surgical or medical treatment for endometrial cancer and died 23 months later. There were three (7.5%) metachronous cancers out of 40 gynecologic cancers; two patients were explained above, the third patient with endometrium cancer, who was not histopathologically evaluated although the axillary [SUV.sub.max] was <3, had rectosigmoid cancer and glioblastoma metachronously. Conclusion: Our study shows that an important ratio (14-21%) of patients with gynecologic cancer has suspicious axillary lymph nodes. Increased [SUV.sub.max], particularly above 3, might be used as an indication for axillary biopsy and may help to identify secondary metastatic cancer. Keywords: Gynecologic cancers, maximum standardized uptake value, positron emission tomography/computed tomography, metachronous, axillary lymph node Amac: Jinekolojik kanserlerde aksiller lenf nodu tutulumunun prognostik onemi ve tedavisi acisindan kisitli bilgiler mevcuttur. Bu calismanin amaci, jinekolojik kanserlerde supheli aksiller lenf nodu insidansini degerlendirmektir. Gerec ve Yontem: Klinigimize basvuran toplam 251 endometrium, serviks veya over kanseri tanisi konulmus hastalarin pozitron emisyon tomografsi-bilgisayarli tomograf bulgularini retrospektif olarak analiz ettik. Jinekolojik kanserler icin aksiller metastazi acidan belgelenen herhangi bir sinir deger belirlenmemis olmasi nedeniyle calismamizda meme kanseri icin belirlenen standart uptake degerini (SUV) sinir deger olarak kabul ettik. Bulgular: Analizler icin toplam 251 hasta kaydi mevcuttu. Supheli aksiller lenf nodu olan 40 hasta (%15,9) calismaya dahil edildi. Endometrium kanseri olan hastalarin %21,5'inde (n=20/93), over kanseri olan hastalarin %14,1'inde (n=14/99) ve serviks kanseri olan hastalarin %10'unda (n=6/59) supheli aksiller lenf nodu tespit edildi. Maksimum SUV ([SUV.sub.maks]) degeri 3'ten yuksek bulunan 5 hastada aksiller lenf nodundan biyopsi alindi. Patolojik degerlendirmede hicbir hastada primer jinekolojik kansere ait aksiller metastaz saptanmadi. Endometrium kanseri olan bir hastada invaziv meme karsinomu, endometrium kanseri olan baska bir hastada folikuler lenfoma tanisi konuldu. Endometrium kanseri olan ucuncu hastada aksiller lenf nodu biyopsisinde tumor tespit edilmedi ancak tiroid biyopsisinde Hurthle hucre neoplazisi saptandi, bu hasta endometrium kanseri icin herhangi bir cerrahi veya medikal tedaviyi kabul etmedi ve 23 ay sonra hayatini kaybetmistir. Calismamiza supheli aksiller lenf nodu ile dahil olan 40 hastanin 3'unde (%7,5) metakron kanser izlendi; iki hasta yukaridaki paragrafta aciklandi, ucuncu ve endometrium kanser tanisi olan hastada rektosigmoid kanseri ve glioblastoma metakron olarak izlendi, bu hastaya [SUV.sub.maks] <3 olmasi nedeniyle aksiller lenf nodu biyopsisi yapilmamistir. Sonuc: Calismamizda, jinekolojik kanserli hastalarin onemli bir oraninin (%14-21) supheli lenf nodu gozlenmektedir. [SUV.sub.maks] ozellikle 3'un uzerinde olan olgularda aksiller lenf nodu biyopsisi yapilmasi muhtemel ikincil metastatik kanserin belirlemesinde yardimci olabilir. Anahtar Kelimeler: Jinekolojik kanserler, maksimum standart uptake degeri, pozitron emisyon tomografsi/bilgisayarli tomograf metakron, aksiller lenf nodu PRECIS: In gynecologic cancers, patients with suspicious axillary lymph nodes need to be evaluated and further investigated to exclude other causes.</abstract><pub>Galenos Yayinevi Tic. Ltd</pub><doi>10.4274/tjod.12144</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2149-9322 |
ispartof | Turkish journal of obstetrics and gynecology, 2018-06, Vol.15 (2), p.99 |
issn | 2149-9322 |
language | eng |
recordid | cdi_gale_infotracmisc_A556734428 |
source | PubMed Central; Alma/SFX Local Collection |
subjects | Care and treatment CAT scans Diagnosis Lymph nodes Ovarian cancer |
title | Incidence of suspicious axillary lymph node involvement in fluorine-18 fluoro-D-glucose positron emission tomography/computed tomography in gynecologic cancers/Jinekolojik kanserlerde flor-18 floro-D-glukoz pozitron emisyon tomografisi-bilgisayarli tomografide supheli aksiller lenf nodu tutulumunun insidansi |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T02%3A57%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20of%20suspicious%20axillary%20lymph%20node%20involvement%20in%20fluorine-18%20fluoro-D-glucose%20positron%20emission%20tomography/computed%20tomography%20in%20gynecologic%20cancers/Jinekolojik%20kanserlerde%20flor-18%20floro-D-glukoz%20pozitron%20emisyon%20tomografisi-bilgisayarli%20tomografide%20supheli%20aksiller%20lenf%20nodu%20tutulumunun%20insidansi&rft.jtitle=Turkish%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Raoufi,%20Jalal&rft.date=2018-06-01&rft.volume=15&rft.issue=2&rft.spage=99&rft.pages=99-&rft.issn=2149-9322&rft_id=info:doi/10.4274/tjod.12144&rft_dat=%3Cgale%3EA556734428%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A556734428&rfr_iscdi=true |